Vasundhara Rasayans Limited Stocks

146.45Last Updated 28.01.2026

Issuer Rating

5/7

Performance

Strong

Risk

Considerable

Recommendation

Hold

Market Cap

₹ 4.91M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
146.45
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Vasundhara Rasayans Ltd. engages in the manufacture and export of active pharmaceutical products for antacid formulations. The firm offers product in paste, powder and micronized grade of powder. It operates through the export and domestic segment. The company was founded on March 5, 1987 and is headquartered in Hyderabad, India.

Company Valuation

Undervalued
6/7

From both historical and forecast perspectives, the stock is underpriced compared to similar stocks. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks